Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH

(MedPage Today) -- Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel small molecule thyroid hormone receptor agonist achieved statistically significant reductions in liver fat...